Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2012
07/24/2012US8226979 Drug coating providing high drug loading and methods for providing the same
07/24/2012US8226978 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
07/24/2012US8226977 Pharmaceutical composition containing irbesartan
07/24/2012US8226976 Method of using cell-free protein synthesis to produce a membrane protein
07/24/2012US8226975 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
07/24/2012US8226974 Backing layer impermeable to nicotine, of a nicotine containing intermediate matrix layer immediately adjacent to the backing layer, of another nicotine-containing matrix layer, and of a peelable protective layer, wherein the matrix
07/24/2012US8226972 Vaginal delivery of drugs
07/24/2012US8226970 Non-woven fiber fabric
07/24/2012US8226969 Methods for reducing the incidence of mastitis
07/24/2012US8226965 Methods of treating fungal, yeast and mold infections
07/24/2012US8226926 Compositions and methods using microspheres and non-ionic contrast agents
07/24/2012US8226776 Treating protein-containing liquids
07/24/2012CA2685706C Antimicrobial compositions, products, and methods of use
07/24/2012CA2629957C Tablets comprising a core and a medicament-containing coating for buccal release
07/24/2012CA2622713C Anthelmintic formulations
07/24/2012CA2617941C Psychostimulant containing pharmaceutical composition
07/24/2012CA2566687C The use of tiacumicin b in the treatment of antibiotic resistant staphylococcus or vancomycin-resistant enterococci infections
07/24/2012CA2536482C Penetrating pharmaceutical foam
07/24/2012CA2535724C Compositions containing topical active agents and pentylene glycol
07/24/2012CA2490116C Acidic insulin preparations with improved stability
07/24/2012CA2488121C Micelle assemblies
07/24/2012CA2477053C Composition for easing human childbirth
07/24/2012CA2473700C Method for stabilizing reduced coenzyme q10 and composition therefor
07/24/2012CA2458146C Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
07/24/2012CA2438334C Ocular tear growth factor-like protein
07/24/2012CA2386716C Magnesium salt of s-omeprazole
07/24/2012CA2256327C Polysaccharide sponges for cell culture and transplantation
07/19/2012WO2012097347A1 Methods for preparing vesicles and formulations produced therefrom
07/19/2012WO2012097281A2 Injectable filler for podiatric and orthopedic uses
07/19/2012WO2012097258A2 Formulations for the prevention and treatment of wolbachia-related disease
07/19/2012WO2012097255A2 Therapeutic effect of heat shock proteins in preventing amylin aggregation in type 2 diabetes mellitus
07/19/2012WO2012097222A1 High drug load tablet formulation of brivanib alaninate
07/19/2012WO2012097220A2 Novel vesicles and nanostructures from recombinant proteins
07/19/2012WO2012097197A1 Donepezil transdermal patch
07/19/2012WO2012097049A2 Dna repair enzyme inhibitor nanoparticles and uses thereof
07/19/2012WO2012097017A1 Compositions comprising crosslinked cation- binding polymers and calcium and/or magnesium cations, and uses thereof
07/19/2012WO2012097011A1 Compositions comprising crosslinked cation- binding polymers and a base, uses thereof
07/19/2012WO2012096985A1 Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
07/19/2012WO2012096939A2 Highly concentrated liquid acetaminophen solutions
07/19/2012WO2012096926A2 Method for delivering agents into cells using bacterial toxins
07/19/2012WO2012096859A2 Oral dosage forms of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl]-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide
07/19/2012WO2012096697A1 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
07/19/2012WO2012096399A1 Particle composition and pharmaceutical composition using particle composition
07/19/2012WO2012095877A1 Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
07/19/2012WO2012095853A1 Modified release formulations comprising sip receptor modulators
07/19/2012WO2012095774A1 Self assembled nanostructured saliva substitutes
07/19/2012WO2012095746A2 New hard capsules
07/19/2012WO2012095607A1 Preventive effect of citrulline on the spontaneous development of tumors
07/19/2012WO2012095543A1 Nanocapsules with a polymer shell
07/19/2012WO2012095536A1 Implant comprising a core and a tube encasing the core
07/19/2012WO2012095523A1 Analgesic composition for transbuccal administration
07/19/2012WO2012095500A2 Pharmaceutical compositions for the treatment of parasitic diseases, cancer, or skin diseases by topical administration
07/19/2012WO2012095439A1 Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
07/19/2012WO2012095438A1 Particles and suspensions of cephalosporin antibiotics
07/19/2012WO2012095307A1 Functionalised materials, process for the production and uses thereof
07/19/2012WO2012095151A1 Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof
07/19/2012WO2012094833A1 Petroleum ether extract of traditional chinese medicine for prevention and treatment of sugar and lipid metabolism disorders and preparation method thereof
07/19/2012WO2012075319A3 Pharmaceutical cream compositions comprising oxymetazoline
07/19/2012WO2012074231A3 Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
07/19/2012WO2012069658A3 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders
07/19/2012WO2012068998A3 Triamcinolone acetonide ophthalmic preparation and preparation method thereof
07/19/2012WO2012068549A3 Therapeutic agent formulations for implanted devices
07/19/2012WO2012064303A3 Improved montelukast combinations
07/19/2012WO2012064302A3 Improved montelukast formulations
07/19/2012WO2012064301A3 Physically improved tablet formulations
07/19/2012WO2012064088A3 Pharmaceutical composition including polymer microsphere containing olanzapine as active ingredient
07/19/2012WO2012064087A3 Pharmaceutical composition including polymer microsphere containing anastrozole as active ingredient
07/19/2012WO2012063498A3 Novel exemestane solid dispersion
07/19/2012WO2012050810A3 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging
07/19/2012WO2012045090A3 Therapeutic use of a tlr agonist and combination therapy
07/19/2012WO2012045089A3 Methods for the treatment of allergic diseases
07/19/2012WO2012027411A3 Compositions and uses of materials with high antimicrobial activity and low toxicity
07/19/2012WO2012021735A3 Pharmaceutical products from fungal strains
07/19/2012WO2012021432A3 Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
07/19/2012WO2012007913A3 Oral administration forms for controlled release of rifampicin or other antibiotics for the treatment of bacterial infections and inflammatory diseases of the gastrointestinal tract
07/19/2012US20120185051 Articular joint implant
07/19/2012US20120184615 Stabilised prostaglandin composition
07/19/2012US20120184601 Antiviral oligonucleotides
07/19/2012US20120184502 Optimised formulation of tobramycin for aerosolization
07/19/2012US20120184011 Emulsion Compositions
07/19/2012US20120183623 Pellets Coated With Coatings Containing Active Substances
07/19/2012US20120183622 Encapsulated cells and composites thereof
07/19/2012US20120183621 Synergistic combinations to reduce particle dose for targeted treatment of cancer and its metastases
07/19/2012US20120183620 mesoporous drug delivery system using an electrically conductive polymer
07/19/2012US20120183618 Modular systems for the controlled release of a substance with space and time control
07/19/2012US20120183617 Composition and method for treatment of diabetes
07/19/2012US20120183616 Long acting insulin composition
07/19/2012US20120183615 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone
07/19/2012US20120183614 Polyphenol compound absorption promoter and utilization of same
07/19/2012US20120183613 Novel Pharmaceutical Composition
07/19/2012US20120183612 Matrix for sustained, invariant and independent release of active compounds
07/19/2012US20120183611 Oral pharmaceutical composition comprising diclofenac
07/19/2012US20120183610 glucocorticoid therapy
07/19/2012US20120183609 Modular systems for the controlled release of a substance with space and time control
07/19/2012US20120183608 Highly concentrated liquid acetaminophen solutions
07/19/2012US20120183607 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
07/19/2012US20120183606 Drug delivery system comprising polyoxazoline and a bioactive agent
07/19/2012US20120183605 Quinine formulations, method of making, and method of use thereof
07/19/2012US20120183604 Treatment of Triple Receptor Negative Breast Cancer
07/19/2012US20120183603 Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
1 ... 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 ... 2991